Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Gilead Sciences EBITDA 2010-2024 | GILD

Gilead Sciences annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Gilead Sciences EBITDA for the quarter ending September 30, 2024 was $1.578B, a 52.28% decline year-over-year.
  • Gilead Sciences EBITDA for the twelve months ending September 30, 2024 was $3.585B, a 66.78% decline year-over-year.
  • Gilead Sciences 2023 annual EBITDA was $10.298B, a 9.17% increase from 2022.
  • Gilead Sciences 2022 annual EBITDA was $9.433B, a 21.18% decline from 2021.
  • Gilead Sciences 2021 annual EBITDA was $11.968B, a 115.6% increase from 2020.
  
Gilead Sciences Annual EBITDA
(Millions of US $)
2023 $10,298
2022 $9,433
2021 $11,968
2020 $5,551
2019 $5,691
2018 $9,629
2017 $15,410
2016 $18,791
2015 $23,291
2014 $16,315
2013 $4,869
2012 $4,288
2011 $4,092
2010 $4,228
2009 $3,742
Gilead Sciences Quarterly EBITDA
(Millions of US $)
2024-09-30 $1,578
2024-06-30 $3,338
2024-03-31 $-3,632
2023-12-31 $2,301
2023-09-30 $3,307
2023-06-30 $2,346
2023-03-31 $2,344
2022-12-31 $2,795
2022-09-30 $3,362
2022-06-30 $2,554
2022-03-31 $722
2021-12-31 $1,475
2021-09-30 $4,365
2021-06-30 $2,765
2021-03-31 $3,363
2020-12-31 $3,078
2020-09-30 $2,356
2020-06-30 $-2,634
2020-03-31 $2,751
2019-12-31 $1,443
2019-09-30 $-1,126
2019-06-30 $2,778
2019-03-31 $2,596
2018-12-31 $1,502
2018-09-30 $2,981
2018-06-30 $2,636
2018-03-31 $2,510
2017-12-31 $2,688
2017-09-30 $4,109
2017-06-30 $4,552
2017-03-31 $4,061
2016-12-31 $4,337
2016-09-30 $4,698
2016-06-30 $4,822
2016-03-31 $4,934
2015-12-31 $5,899
2015-09-30 $5,863
2015-06-30 $5,889
2015-03-31 $5,640
2014-12-31 $4,605
2014-09-30 $3,748
2014-06-30 $4,678
2014-03-31 $3,284
2013-12-31 $1,325
2013-09-30 $1,217
2013-06-30 $1,227
2013-03-31 $1,100
2012-12-31 $1,180
2012-09-30 $1,115
2012-06-30 $1,127
2012-03-31 $866
2011-12-31 $941
2011-09-30 $1,077
2011-06-30 $1,092
2011-03-31 $983
2010-12-31 $907
2010-09-30 $1,048
2010-06-30 $1,051
2010-03-31 $1,221
2009-12-31 $1,130
2009-09-30 $951
2009-06-30 $814
2009-03-31 $847
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $112.401B $27.116B
Gilead Sciences is a pioneer in developing drugs for the treatment of human immunodeficiency virus, liver diseases, hematology/oncology diseases and inflammation/respiratory diseases. The company has a strong HIV franchise with key HIV/AIDS therapies like tenofovir alafenamide based products - Genvoya, Odefsey, Descovy, Biktarvy and Truvada. The portfolio also includes hepatitis C virus drugs like Harvoni and Epclusa and HBV drug. The first cell therapy approved for the treatment of adult patients with relapsed or refractory large B-cell lymphoma, has diversified Gilead's portfolio. Tecartus, another CAR T-cell therapy, was granted an accelerated approval in the United States for the treatment of relapsed or refractory mantle cell lymphoma. The company is also working on diversifying and growing its business beyond antivirals into other therapeutic areas. Gilead is also making inroads in the oncology space with strategic collaborations and acquisitions.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $158.320B 15.32
Bristol Myers Squibb (BMY) United States $119.399B 50.32
Vertex Pharmaceuticals (VRTX) United States $116.138B 0.00
CSL (CSLLY) Australia $87.157B 0.00
Regeneron Pharmaceuticals (REGN) United States $81.099B 18.46
GSK (GSK) United Kingdom $70.384B 8.14
Argenex SE (ARGX) Netherlands $36.232B 0.00
Alnylam Pharmaceuticals (ALNY) United States $31.586B 0.00
BioNTech SE (BNTX) Germany $27.122B 0.00
Biogen (BIIB) United States $23.009B 9.88
Illumina (ILMN) United States $22.226B 81.01
BeiGene (BGNE) Cayman Islands $18.555B 0.00
Moderna (MRNA) United States $15.820B 0.00
Incyte (INCY) United States $13.817B 0.00
Genmab (GMAB) Denmark $13.666B 20.05
Insmed (INSM) United States $13.087B 0.00
BioMarin Pharmaceutical (BMRN) United States $12.247B 28.43
Bio-Techne Corp (TECH) United States $11.326B 43.73
Vaxcyte (PCVX) United States $11.035B 0.00
Sarepta Therapeutics (SRPT) United States $10.911B 98.47
Exelixis (EXEL) United States $10.169B 23.12
Exact Sciences (EXAS) United States $9.792B 0.00
QIAGEN (QGEN) Netherlands $9.763B 20.08
Revolution Medicines (RVMD) United States $9.546B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.375B 31.86
Roivant Sciences (ROIV) United Kingdom $9.266B 0.00
Intra-Cellular Therapies (ITCI) United States $9.085B 0.00
Repligen (RGEN) United States $7.988B 104.07
Ascendis Pharma (ASND) Denmark $7.872B 0.00
Legend Biotech (LEGN) United States $7.464B 0.00
Nuvalent (NUVL) United States $6.745B 0.00
Halozyme Therapeutics (HALO) United States $6.234B 14.08
Blueprint Medicines (BPMC) United States $5.981B 0.00
Viking Therapeutics (VKTX) United States $5.860B 0.00
Cytokinetics (CYTK) United States $5.794B 0.00
Krystal Biotech (KRYS) United States $5.476B 90.67
Avidity Biosciences (RNA) United States $5.160B 0.00
ADMA Biologics Inc (ADMA) United States $5.007B 52.95
Arcellx (ACLX) United States $4.891B 0.00
Axsome Therapeutics (AXSM) United States $4.782B 0.00
Alkermes (ALKS) Ireland $4.657B 15.64
Biohaven (BHVN) United States $4.610B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.362B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.087B 0.00
Guardant Health (GH) United States $4.034B 0.00
Immunovant (IMVT) United States $3.944B 0.00
Apellis Pharmaceuticals (APLS) United States $3.828B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.684B 0.00
ImmunityBio (IBRX) United States $3.554B 0.00
Denali Therapeutics (DNLI) United States $3.553B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.471B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.137B 0.00
Merus (MRUS) Netherlands $3.114B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $3.102B 0.00
Vera Therapeutics (VERA) United States $3.059B 0.00
Edgewise Therapeutics (EWTX) United States $3.049B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.026B 0.00
Vericel (VCEL) United States $2.918B 985.17
Kymera Therapeutics (KYMR) United States $2.913B 0.00
SpringWorks Therapeutics (SWTX) United States $2.903B 0.00
Amicus Therapeutics (FOLD) United States $2.886B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $2.886B 0.00
Scholar Rock Holding (SRRK) United States $2.801B 0.00
Protagonist Therapeutics (PTGX) United States $2.769B 17.47
ACADIA Pharmaceuticals (ACAD) United States $2.724B 20.99
Janux Therapeutics (JANX) United States $2.640B 0.00
Zai Lab (ZLAB) China $2.633B 0.00
Iovance Biotherapeutics (IOVA) United States $2.606B 0.00
Twist Bioscience (TWST) United States $2.507B 0.00
Geron (GERN) United States $2.460B 0.00
Belite Bio (BLTE) United States $2.456B 0.00
Longboard Pharmaceuticals (LBPH) United States $2.335B 0.00
IDEAYA Biosciences (IDYA) United States $2.316B 0.00
Akero Therapeutics (AKRO) United States $2.285B 0.00
Keros Therapeutics (KROS) United States $2.265B 0.00
CG Oncology (CGON) United States $2.264B 0.00
Ligand Pharmaceuticals (LGND) United States $2.252B 56.22
WAVE Life Sciences (WVE) Singapore $2.176B 0.00
Bavarian Nordic (BVNRY) Denmark $2.171B 13.30
Mirum Pharmaceuticals (MIRM) United States $2.147B 0.00
NeoGenomics (NEO) United States $2.104B 0.00
Beam Therapeutics (BEAM) United States $2.074B 0.00
Apogee Therapeutics (APGE) United States $1.957B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.943B 16.15
Disc Medicine (IRON) United States $1.933B 0.00
NovoCure (NVCR) Jersey $1.918B 0.00
Structure Therapeutics (GPCR) United States $1.913B 0.00
MannKind (MNKD) United States $1.886B 48.86
Tarsus Pharmaceuticals (TARS) United States $1.844B 0.00
Celldex Therapeutics (CLDX) United States $1.793B 0.00
Galapagos (GLPG) Belgium $1.788B 0.00
Arvinas (ARVN) United States $1.777B 0.00
Fortrea Holdings (FTRE) United States $1.770B 56.37
Certara (CERT) United States $1.668B 47.09
Dynavax Technologies (DVAX) United States $1.633B 95.54
Immunocore Holdings (IMCR) United Kingdom $1.615B 0.00
Viridian Therapeutics (VRDN) United States $1.600B 0.00
Neumora Therapeutics (NMRA) United States $1.574B 0.00
Nurix Therapeutics (NRIX) United States $1.562B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.536B 0.00
Intellia Therapeutics (NTLA) United States $1.456B 0.00
Spyre Therapeutics (SYRE) United States $1.425B 0.00
Travere Therapeutics (TVTX) United States $1.424B 0.00
Myriad Genetics (MYGN) United States $1.410B 0.00
Praxis Precision Medicines (PRAX) United States $1.389B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.384B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.373B 0.00
Novavax (NVAX) United States $1.357B 0.00
MiMedx (MDXG) United States $1.352B 35.38
Arcus Biosciences (RCUS) United States $1.345B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.286B 0.00
ANI Pharmaceuticals (ANIP) United States $1.197B 16.31
Arcutis Biotherapeutics (ARQT) United States $1.187B 0.00
Mesoblast (MESO) Australia $1.154B 0.00
Applied Therapeutics (APLT) United States $1.120B 0.00
Gyre Therapeutics (GYRE) United States $1.056B 0.00
Replimune (REPL) United States $1.021B 0.00
Cogent Biosciences (COGT) United States $1.009B 0.00
Bicara Therapeutics (BCAX) United States $0.984B 0.00
Zymeworks (ZYME) United States $0.984B 0.00
Vir Biotechnology (VIR) United States $0.981B 0.00
Septerna (SEPN) $0.977B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.977B 0.00
LENZ Therapeutics (LENZ) United States $0.976B 0.00
Upstream Bio (UPB) United States $0.975B 0.00
Nuvation Bio (NUVB) United States $0.942B 0.00
89BIO (ETNB) United States $0.930B 0.00
ArriVent BioPharma (AVBP) United States $0.925B 0.00
Immatics (IMTX) Germany $0.906B 0.00
Liquidia Technologies (LQDA) United States $0.901B 0.00
Rapport Therapeutics (RAPP) United States $0.845B 0.00
Cytek Biosciences (CTKB) United States $0.844B 0.00
Kura Oncology (KURA) United States $0.840B 0.00
Castle Biosciences (CSTL) United States $0.835B 149.05
AbCellera Biologics (ABCL) Canada $0.815B 0.00
Pacira BioSciences (PCRX) United States $0.810B 7.63
Tyra Biosciences (TYRA) United States $0.801B 0.00
Pliant Therapeutics (PLRX) United States $0.790B 0.00
Prothena (PRTA) Ireland $0.786B 0.00
Avid Bioservices (CDMO) United States $0.785B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.782B 0.00
Anavex Life Sciences (AVXL) United States $0.772B 0.00
Erasca (ERAS) United States $0.763B 0.00
CARGO Therapeutics (CRGX) United States $0.747B 0.00
Cullinan Therapeutics (CGEM) United States $0.730B 0.00
Tectonic Therapeutic (TECX) United States $0.710B 0.00
Entrada Therapeutics (TRDA) United States $0.704B 11.82
Adaptive Biotechnologies (ADPT) United States $0.692B 0.00
BioAge Labs (BIOA) United States $0.686B 0.00
AnaptysBio (ANAB) United States $0.678B 0.00
Oric Pharmaceuticals (ORIC) United States $0.677B 0.00
Arbutus Biopharma (ABUS) United States $0.665B 0.00
Dianthus Therapeutics (DNTH) United States $0.661B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.639B 0.00
Mineralys Therapeutics (MLYS) United States $0.622B 0.00
MBX Biosciences (MBX) United States $0.618B 0.00
Immunome (IMNM) United States $0.613B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.611B 0.00
Stoke Therapeutics (STOK) United States $0.605B 0.00
CorMedix Inc (CRMD) United States $0.604B 0.00
Oculis Holding AG (OCS) Switzerland $0.598B 0.00
CureVac (CVAC) Germany $0.596B 4.84
Sana Biotechnology (SANA) United States $0.583B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.575B 0.00
ChromaDex (CDXC) United States $0.568B 744.00
Humacyte (HUMA) United States $0.565B 0.00
Third Harmonic Bio (THRD) United States $0.562B 0.00
Abivax SA (ABVX) France $0.556B 0.00
GRAIL (GRAL) United States $0.555B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.554B 0.00
Annexon (ANNX) United States $0.548B 0.00
Astria Therapeutics (ATXS) United States $0.545B 0.00
PureTech Health (PRTC) United States $0.540B 0.00
IGM Biosciences (IGMS) United States $0.529B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.522B 0.00
Emergent Biosolutions (EBS) United States $0.514B 0.00
Pharming Group (PHAR) Netherlands $0.511B 0.00
Olema Pharmaceuticals (OLMA) United States $0.503B 0.00
Zenas BioPharma (ZBIO) United States $0.501B 0.00
Terns Pharmaceuticals (TERN) United States $0.492B 0.00
Celcuity (CELC) United States $0.490B 0.00
GH Research (GHRS) Ireland $0.482B 0.00
Cartesian Therapeutics (RNAC) United States $0.480B 0.00
REGENXBIO (RGNX) United States $0.475B 0.00
ACELYRIN, INC (SLRN) United States $0.472B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.466B 0.00
MeiraGTx Holdings (MGTX) United States $0.463B 0.00
Allogene Therapeutics (ALLO) United States $0.463B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.458B 0.00
Aura Biosciences (AURA) United States $0.447B 0.00
Alumis (ALMS) United States $0.447B 0.00
Foghorn Therapeutics (FHTX) United States $0.436B 0.00
Tango Therapeutics (TNGX) United States $0.421B 0.00
Prime Medicine (PRME) United States $0.420B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.413B 0.00
Sangamo Therapeutics (SGMO) United States $0.392B 0.00
Revance Therapeutics (RVNC) United States $0.391B 0.00
Alpha Teknova (TKNO) United States $0.391B 0.00
Alector (ALEC) United States $0.386B 0.00
Codexis (CDXS) United States $0.375B 0.00
MaxCyte (MXCT) United States $0.374B 0.00
Contineum Therapeutics (CTNM) United States $0.363B 0.00
XOMA Royalty (XOMA) United States $0.356B 0.00
Northwest Biotherapeutics (NWBO) United States $0.354B 0.00
EnGene Holdings (ENGN) Canada $0.340B 0.00
Kamada (KMDA) Israel $0.337B 20.96
AC Immune (ACIU) Switzerland $0.334B 0.00
Jasper Therapeutics (JSPR) United States $0.331B 0.00
Kodiak Sciences (KOD) United States $0.326B 0.00
Design Therapeutics (DSGN) United States $0.318B 0.00
Voyager Therapeutics (VYGR) United States $0.309B 7.96
ITeos Therapeutics (ITOS) United States $0.304B 0.00
Neurogene (NGNE) United States $0.302B 0.00
Nautilus Biotechnology (NAUT) United States $0.301B 0.00
C4 Therapeutics (CCCC) United States $0.300B 0.00
Q32 Bio (QTTB) United States $0.299B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.297B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.296B 0.00
Absci (ABSI) United States $0.294B 0.00
Eton Pharmaceuticals (ETON) United States $0.290B 0.00
Atea Pharmaceuticals (AVIR) United States $0.285B 0.00
Rezolute (RZLT) United States $0.285B 0.00
UniQure (QURE) Netherlands $0.282B 0.00
Prima BioMed (IMMP) Australia $0.280B 0.00
Urogen Pharma (URGN) United States $0.279B 0.00
Artiva Biotherapeutics (ARTV) United States $0.272B 0.00
Lifecore Biomedical (LFCR) United States $0.269B 0.00
Poseida Therapeutics (PSTX) United States $0.266B 0.00
Ocugen (OCGN) United States $0.264B 0.00
Precigen (PGEN) United States $0.264B 0.00
Fate Therapeutics (FATE) United States $0.261B 0.00
Abeona Therapeutics (ABEO) United States $0.260B 0.00
Semper Paratus Acquisition (TVGN) United States $0.256B 0.00
ATyr Pharma (ATYR) United States $0.254B 0.00
Mersana Therapeutics (MRSN) United States $0.252B 0.00
Anika Therapeutics (ANIK) United States $0.249B 0.00
Benitec Biopharma (BNTC) United States $0.244B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.240B 0.00
Biomea Fusion (BMEA) United States $0.233B 0.00
BioStem Technologies (BSEM) $0.231B 20.47
Zentalis Pharmaceuticals (ZNTL) United States $0.230B 0.00
TScan Therapeutics (TCRX) United States $0.227B 0.00
Amarin (AMRN) Ireland $0.225B 0.00
Trevi Therapeutics (TRVI) United States $0.224B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.219B 0.00
Solid Biosciences (SLDB) United States $0.216B 0.00
Molecular Partners AG (MOLN) Switzerland $0.213B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.213B 0.00
GENFIT S.A (GNFT) France $0.210B 0.00
XBiotech (XBIT) United States $0.208B 0.00
Sutro Biopharma (STRO) United States $0.207B 0.00
Climb Bio (CLYM) United States $0.205B 0.00
Compass Therapeutics (CMPX) United States $0.205B 0.00
Inhibrx Biosciences (INBX) United States $0.204B 0.00
Editas Medicine (EDIT) United States $0.201B 0.00
DiaMedica Therapeutics (DMAC) United States $0.201B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.192B 0.00
Kyverna Therapeutics (KYTX) United States $0.190B 0.00
Tenaya Therapeutics (TNYA) United States $0.189B 0.00
2seventy Bio (TSVT) United States $0.186B 0.00
Opthea (OPT) Australia $0.185B 0.00
Checkpoint Therapeutics (CKPT) United States $0.183B 0.00
Caribou Biosciences (CRBU) United States $0.183B 0.00
Inozyme Pharma (INZY) United States $0.181B 0.00
Zura Bio (ZURA) United States $0.178B 0.00
Greenwich LifeSciences (GLSI) United States $0.178B 0.00
Verastem (VSTM) United States $0.178B 0.00
Actuate Therapeutics (ACTU) United States $0.175B 0.00
Fulcrum Therapeutics (FULC) United States $0.175B 0.00
Nkarta (NKTX) United States $0.173B 0.00
Instil Bio (TIL) United States $0.171B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.169B 0.00
ScPharmaceuticals (SCPH) United States $0.168B 0.00
Candel Therapeutics (CADL) United States $0.164B 0.00
TuHURA Biosciences (HURA) United States $0.159B 0.00
Gossamer Bio (GOSS) United States $0.158B 0.00
Bright Minds Biosciences (DRUG) United States $0.157B 0.00
Puma Biotechnology (PBYI) United States $0.147B 6.25
Sagimet Biosciences (SGMT) United States $0.146B 0.00
Adherex Technologies (FENC) United States $0.146B 0.00
Cidara Therapeutics (CDTX) United States $0.144B 0.00
PepGen (PEPG) United States $0.144B 0.00
Black Diamond Therapeutics (BDTX) United States $0.144B 0.00
Seer (SEER) United States $0.143B 0.00
Elutia (ELUT) United States $0.142B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.142B 0.00
Inventiva S.A (IVA) France $0.137B 0.00
Innate Pharma S.A (IPHA) France $0.132B 0.00
Seres Therapeutics (MCRB) United States $0.131B 0.00
Ventyx Biosciences (VTYX) United States $0.131B 0.00
Vigil Neuroscience (VIGL) United States $0.130B 0.00
Compugen (CGEN) Israel $0.126B 70.50
Adverum Biotechnologies (ADVM) United States $0.126B 0.00
Coherus BioSciences (CHRS) United States $0.126B 0.00
Cardiff Oncology (CRDF) United States $0.125B 0.00
Skye Bioscience (SKYE) United States $0.125B 0.00
InflaRx (IFRX) Germany $0.122B 0.00
Repare Therapeutics (RPTX) Canada $0.119B 0.00
Rani Therapeutics Holdings (RANI) United States $0.119B 0.00
Oncobiologics (OTLK) United States $0.119B 0.00
TELA Bio (TELA) United States $0.119B 0.00
Alto Neuroscience (ANRO) United States $0.116B 0.00
Coya Therapeutics (COYA) United States $0.109B 0.00
INmune Bio (INMB) United States $0.108B 0.00
Inovio Pharmaceuticals (INO) United States $0.106B 0.00
Monopar Therapeutics (MNPR) United States $0.106B 0.00
CAMP4 Therapeutics (CAMP) United States $0.106B 0.00
Akoya Biosciences (AKYA) United States $0.105B 0.00
MediciNova (MNOV) United States $0.104B 0.00
Cellectis S.A (CLLS) France $0.104B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.103B 0.00
BioHarvest Sciences (BHST) Canada $0.102B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.100B 0.00
Scilex Holding (SCLX) United States $0.100B 0.00
Immunic (IMUX) United States $0.099B 0.00
Nuvectis Pharma (NVCT) United States $0.099B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.098B 0.00
Leap Therapeutics (LPTX) United States $0.098B 0.00
Adagene (ADAG) China $0.097B 0.00
Adlai Nortye (ANL) Cayman Islands $0.097B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.095B 0.00
HilleVax (HLVX) United States $0.093B 0.00
Annovis Bio (ANVS) United States $0.092B 0.00
Generation Bio (GBIO) United States $0.092B 0.00
Cabaletta Bio (CABA) United States $0.091B 0.00
FibroBiologics (FBLG) United States $0.090B 0.00
Genelux (GNLX) United States $0.088B 0.00
Quince Therapeutics (QNCX) United States $0.086B 0.00
Genenta Science S.p.A (GNTA) Italy $0.086B 0.00
Werewolf Therapeutics (HOWL) United States $0.085B 0.00
Invivyd (IVVD) United States $0.084B 0.00
Ikena Oncology (IKNA) United States $0.083B 0.00
Renovaro (RENB) United States $0.082B 0.00
Galena Biopharma (SLS) United States $0.082B 0.00
Clearside Biomedical (CLSD) United States $0.082B 0.00
23andMe Holding (ME) United States $0.081B 0.00
Chimerix (CMRX) United States $0.081B 0.00
Agenus (AGEN) United States $0.078B 0.00
Allakos (ALLK) United States $0.078B 0.00
PDS Biotechnology (PDSB) United States $0.078B 0.00
Aerovate Therapeutics (AVTE) United States $0.077B 0.00
I-Mab (IMAB) China $0.077B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.076B 0.00
BioAtla (BCAB) United States $0.076B 0.00
Ovid Therapeutics (OVID) United States $0.075B 0.00
ALX Oncology Holdings (ALXO) United States $0.074B 0.00
Adicet Bio (ACET) United States $0.074B 0.00
ZIVO Bioscience (ZIVO) United States $0.074B 0.00
Oncolytics Biotech (ONCY) Canada $0.074B 0.00
Aligos Therapeutics (ALGS) United States $0.072B 0.00
VistaGen Therapeutics (VTGN) United States $0.072B 0.00
CytomX Therapeutics (CTMX) United States $0.070B 5.24
Bluebird Bio (BLUE) United States $0.068B 0.00
BeyondSpring (BYSI) United States $0.068B 0.00
Atara Biotherapeutics (ATRA) United States $0.066B 0.00
Immuneering (IMRX) United States $0.065B 0.00
Cue Biopharma (CUE) United States $0.065B 0.00
Spero Therapeutics (SPRO) United States $0.063B 16.57
Celularity (CELU) United States $0.061B 0.00
CervoMed (CRVO) United States $0.059B 0.00
X4 Pharmaceuticals (XFOR) United States $0.058B 0.00
Dyadic (DYAI) United States $0.057B 0.00
Entera Bio (ENTX) Israel $0.057B 0.00
Aadi Bioscience (AADI) United States $0.057B 0.00
Precision BioSciences (DTIL) United States $0.056B 0.00
Connect Biopharma Holdings (CNTB) United States $0.055B 0.00
Theratechnologies (THTX) Canada $0.055B 0.00
Kezar Life Sciences (KZR) United States $0.055B 0.00
Kronos Bio (KRON) United States $0.054B 0.00
Earth Science Tech (ETST) United States $0.054B 0.00
Vor Biopharma (VOR) $0.054B 0.00
Aileron Therapeutics (ALRN) United States $0.054B 0.00
Elicio Therapeutics (ELTX) United States $0.053B 0.00
Boundless Bio (BOLD) United States $0.052B 0.00
OnKure Therapeutics (OKUR) United States $0.052B 0.00
Enzo Biochem (ENZ) United States $0.051B 0.00
BGM Group (BGM) China $0.051B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.050B 0.00
Immix Biopharma (IMMX) United States $0.049B 0.00
Shattuck Labs (STTK) United States $0.048B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.047B 0.00
IO Biotech (IOBT) Denmark $0.047B 0.00
CalciMedica (CALC) United States $0.047B 0.00
DBV Technologies S.A (DBVT) France $0.045B 0.00
VTv Therapeutics (VTVT) United States $0.045B 0.00
Fortress Biotech (FBIO) United States $0.044B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.044B 0.00
Omega Therapeutics (OMGA) United States $0.044B 0.00
Rallybio (RLYB) United States $0.042B 0.00
Affimed (AFMD) Germany $0.042B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.040B 0.00
AN2 Therapeutics (ANTX) United States $0.040B 0.00
Exicure (XCUR) United States $0.040B 0.00
Xilio Therapeutics (XLO) United States $0.039B 0.00
Beyond Air (XAIR) United States $0.039B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.038B 0.00
Rapt Therapeutics (RAPT) United States $0.038B 0.00
Lumos Pharma (LUMO) United States $0.037B 0.00
Intensity Therapeutics (INTS) United States $0.036B 0.00
Elevation Oncology (ELEV) United States $0.036B 0.00
OKYO Pharma (OKYO) $0.036B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.035B 0.00
Clene (CLNN) United States $0.035B 0.00
Alpha Cognition (ACOG) Canada $0.035B 0.00
Curis (CRIS) United States $0.034B 0.00
Promis Neurosciences (PMN) Canada $0.034B 0.00
NextCure (NXTC) United States $0.033B 0.00
Grace Therapeutics (GRCE) Canada $0.033B 0.00
Lantern Pharma (LTRN) United States $0.033B 0.00
Lexaria Bioscience (LEXX) Canada $0.033B 0.00
Estrella Immunopharma (ESLA) United States $0.033B 0.00
Opus Genetics (IRD) United States $0.032B 0.00
KALA BIO (KALA) United States $0.031B 0.00
Passage Bio (PASG) United States $0.031B 0.00
RenovoRx (RNXT) United States $0.031B 0.00
HCW Biologics (HCWB) United States $0.029B 0.00
Dare Bioscience (DARE) United States $0.029B 0.00
SAB Biotherapeutics (SABS) United States $0.029B 0.00
Longeveron (LGVN) United States $0.028B 0.00
GeoVax Labs (GOVX) United States $0.028B 0.00
Pluri (PLUR) Israel $0.027B 0.00
MiNK Therapeutics (INKT) United States $0.027B 0.00
BRIACELL THERAP (BCTX) Canada $0.026B 0.00
HOOKIPA Pharma (HOOK) United States $0.026B 0.00
Equillium (EQ) United States $0.025B 0.00
Ocean Biomedical (OCEA) United States $0.025B 0.00
Cadrenal Therapeutics (CVKD) United States $0.025B 0.00
Athira Pharma (ATHA) United States $0.025B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.025B 0.00
LakeShore Biopharma (LSB) China $0.024B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
Femasys (FEMY) United States $0.024B 0.00
Chemomab Therapeutics (CMMB) Israel $0.024B 0.00
Forte Biosciences (FBRX) United States $0.023B 0.00
Bionano Genomics (BNGO) United States $0.023B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.023B 0.00
Cocrystal Pharma (COCP) United States $0.022B 0.00
Pulmatrix (PULM) United States $0.022B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.022B 0.00
Bolt Biotherapeutics (BOLT) United States $0.022B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.022B 0.00
BioXcel Therapeutics (BTAI) United States $0.022B 0.00
Cyclo Therapeutics (CYTH) United States $0.021B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.020B 0.00
Spruce Biosciences (SPRB) United States $0.020B 0.00
UNITY Biotechnology (UBX) United States $0.019B 0.00
BioAffinity Technologies (BIAF) United States $0.019B 0.00
Cognition Therapeutics (CGTX) United States $0.018B 0.00
Gelteq (GELS) $0.017B 0.00
Tenax Therapeutics (TENX) United States $0.017B 0.00
Cara Therapeutics (CARA) United States $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.016B 0.00
Aprea Therapeutics (APRE) United States $0.016B 0.00
Novogen (KZIA) Australia $0.015B 0.00
Cingulate (CING) United States $0.015B 0.00
Sensei Biotherapeutics (SNSE) United States $0.013B 0.00
NKGen Biotech (NKGN) United States $0.012B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.012B 0.00
Imunon (IMNN) United States $0.012B 0.00
Turnstone Biologics (TSBX) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.011B 0.00
Elevai Labs (ELAB) United States $0.010B 0.00
Quantum Biopharma (QNTM) Canada $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Biorestorative Therapies (BRTX) United States $0.010B 0.00
Aytu BioPharma (AYTU) United States $0.010B 0.00
Apollomics (APLM) United States $0.010B 0.00
Senti Biosciences (SNTI) United States $0.010B 0.00
Mustang Bio (MBIO) United States $0.010B 0.00
Vaccinex (VCNX) United States $0.009B 0.00
GENPREX (GNPX) United States $0.009B 0.00
Eyenovia (EYEN) United States $0.009B 0.00
Onconetix (ONCO) United States $0.009B 0.00
Evaxion Biotech (EVAX) Denmark $0.009B 0.00
Evogene (EVGN) Israel $0.009B 0.00
Vincerx Pharma (VINC) United States $0.008B 0.00
Ensysce Biosciences (ENSC) United States $0.008B 0.00
Soligenix (SNGX) United States $0.008B 0.00
Moleculin Biotech (MBRX) United States $0.008B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.008B 0.00
Syros Pharmaceuticals (SYRS) United States $0.008B 0.00
Prana Biotechnology (ATHE) Australia $0.008B 0.00
Biora Therapeutics (BIOR) United States $0.008B 0.00
Galecto (GLTO) Denmark $0.007B 0.00
CNS Pharmaceuticals (CNSP) United States $0.007B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Edesa Biotech (EDSA) Canada $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Biofrontera (BFRI) United States $0.007B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
GRI Bio (GRI) United States $0.006B 0.00
Organovo Holdings (ONVO) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Aptevo Therapeutics (APVO) United States $0.006B 0.00
Allarity Therapeutics (ALLR) United States $0.006B 0.00
Carmell (CTCX) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
Bionomics (BNOX) Australia $0.005B 0.00
Portage Biotech (PRTG) $0.005B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.004B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
NAYA Biosciences (NAYA) United States $0.004B 0.00
Pasithea Therapeutics (KTTA) United States $0.004B 0.00
Polyrizon (PLRZ) $0.004B 0.00
Cyclerion Therapeutics (CYCN) United States $0.004B 0.00
Silo Pharma (SILO) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
IN8bio (INAB) United States $0.003B 0.00
Aptose Biosciences (APTO) Canada $0.003B 0.00
Dogwood Therapeutics (DWTX) United States $0.003B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
NuCana (NCNA) United Kingdom $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
Sunshine Biopharma (SBFM) United States $0.003B 0.00
Eterna Therapeutics (ERNA) United States $0.003B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.002B 0.00
Citius Oncology (CTOR) United States $0.002B 0.00
TFF Pharmaceuticals (TFFP) United States $0.002B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
Windtree Therapeutics (WINT) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00